MedPath

Clinical effect of three additional methods (two antimicrobial photodynamic therapy systems and chlorhexidine) to non-surgical treatment of peri-implantitis: a randomized prospective study

Phase 4
Conditions
Peri-implantitis
Registration Number
DRKS00011171
Lead Sponsor
Klinik für Mund-, Kiefer- und Gesichtschirurgie, Plastische Operationen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion criteria have been a peri-implantitis, which were not treated before with probing depth (PD) > 5 mm, bleeding on probing (BoP) and bone loss in the x-ray

Exclusion Criteria

Exclusion criteria have been to maintain therapy or to receive peri-implant treatment during the last six months; using antimicrobials (systemic or topical), anti-inflammatory or immunosuppressive drugs during the three months preceding the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical (bleeding on probing (BoP), pus, modified plaque index, pocket depth (PD), and crevicular fluid) mikrobiological parameters after three month. measurement of bleeding on probing at 6 probing points with a periodontal probe. Pus registration out of the sulcus was measured clinical. The modified plaque indes of Sillnes and Loe was used. To measure the pocket probing depth a periodontal probe was used. The sulks fluid was measured using blotting paper. The concentration of alpha MMP-8 was examined using a kitten (diagnostika) and the periodontal pathogens have been identified from the company (Hain Life science, MicroIdentPlus).<br><br>
Secondary Outcome Measures
NameTimeMethod
clinical and microbiological parameter from E1-E5
© Copyright 2025. All Rights Reserved by MedPath